Status:

COMPLETED

Hysterectomy - A Regional Intervention Study

Lead Sponsor:

University Hospital, Linkoeping

Conditions:

Benign Hysterectomy

Postoperative Recovery

Eligibility:

FEMALE

18-55 years

Phase:

NA

Brief Summary

Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences in preoperative information, planning of surgery and surgical techn...

Detailed Description

Background Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences between clinics in Sweden in the proportion of hysterect...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Women 18 - 55 years old.
  • Women undergoing hysterectomy for benign indication.
  • Women with ASA 1 - 3.
  • Women who understand and can express themselves in Swedish.
  • Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.
  • Women who participate and respond to the surveys in the GynOp register.
  • Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).
  • Exclusion criteria
  • Women where both ovaries are removed during the operation.
  • Women undergoing hysterectomy for prolapse indication.
  • Women undergoing hysterectomy for cancer prophylactic indication.
  • Women undergoing hysterectomy for gender reassignment purposes.
  • Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.
  • Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.

Exclusion

    Key Trial Info

    Start Date :

    September 4 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2024

    Estimated Enrollment :

    230 Patients enrolled

    Trial Details

    Trial ID

    NCT05255120

    Start Date

    September 4 2020

    End Date

    October 1 2024

    Last Update

    December 16 2024

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University Hospital

    Linköping, Sweden, 58185

    2

    Vrinnevisjukhuset

    Norrköping, Sweden, 58185